|
Digitek
(Digoxin Recall)
Our office is currently investigating cases involving the recalled heart drug, DigitekŪ, (digoxin tablets, USP, all strengths) for oral use. Zoll, Kranz and Borgess, LLC has a strong track record in similar cases, including our efforts on a national level in the Heparin litigation and Sulzer Hip/Knee Implant litigation, as well as the Vioxx and Bextra litigation.
On April 25, 2008, Icelandic generic drug maker Actavis recalled the drug over concerns that some batches of the medicine may have contained twice the approved level of active ingredient than is appropriate.
Digitalis toxicity can cause serious injuries or death. Some of the symptoms may include the following:
-
Visual changes
-
Halos or rings of light around objects
-
Seeing lights or bright spots
-
Changes in color perception
-
Blind spots in vision
-
Blurred vision
-
Confusion
-
Loss of appetite
-
Nausea, vomiting, diarrhea
-
Palpitations
-
Irregular pulse
-
Decreased urine output
-
Excessive nighttime urination
-
Overall swelling
-
Decreased consciousness
-
Difficulty breathing when lying down
If you or someone close to you was given DigitekŪ and suffered serious injury or death, you are urged to contact the law offices of Zoll, Kranz and Borgess, LLC at 419-841-9623 to speak to an attorney. The call is free, and there is no obligation. You may also email us at
pamela@toledolaw.com. To View the Digitek Timeline with Web-Links,
Click Here.
RELATED NEWS ARTICLES AND/OR USEFUL LINKS:
Federal Drug Administration (FDA):
http://www.fda.gov/medwAtch/safety/2008/safety08.htm#Digitek
Actavis Totowa:
http://www.actavis.us/en/media+center/newsroom/articles/digitek+recall.htm
WebMD:
http://www.webmd.com/heart-disease/heart-failure/news/20080428/digitek-tablets-recalled
Medscape:
http://www.medscape.com/viewarticle/573671
|
